At close: June 14 at 4:00 PM EDT
After hours: June 14 at 7:57 PM EDT
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 116,592 | 1 |
| Sales | 72,496 | 2 |
| Net Shares Purchased (Sold) | 44,096 | 3 |
| Total Insider Shares Held | 25.35M | -- |
| % Net Shares Purchased (Sold) | 0.20% | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| RICKARD KATHLEEN A Officer | Sale at price 15.69 per share. | Direct | 568,731 | May 3, 2024 |
| RICKARD KATHLEEN A Officer | Sale at price 18.31 per share. | Direct | 663,701 | Feb 5, 2024 |
| POLL CLAIRE LOUISE General Counsel | Stock Gift at price 0.00 per share. | Direct | 0 | Feb 1, 2024 |
| EDWARDS MARTIN Director | Purchase at price 14.73 per share. | Direct | 496,931 | Nov 20, 2023 |
| EBSWORTH DAVID R Director | Purchase at price 15.12 per share. | Direct | 2,419,200 | Nov 6, 2023 |
| RICKARD KATHLEEN A Officer | Sale at price 15.37 per share. | Direct | 903,018 | Nov 3, 2023 |
| HAHN MARK W. CPA Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Oct 20, 2023 |
| ZACCARDELLI DAVID S Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Oct 20, 2023 |
| RICKARD KATHLEEN A Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Oct 20, 2023 |
| POLL CLAIRE LOUISE General Counsel | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Oct 20, 2023 |
| HAHN MARK W. CPA Chief Financial Officer | Sale at price 19.04 - 20.04 per share. | Direct | 5,503,680 | Aug 7, 2023 |
| ZACCARDELLI DAVID S Chief Executive Officer | Sale at price 19.04 - 20.04 per share. | Direct | 5,503,680 | Aug 7, 2023 |
| RICKARD KATHLEEN A Officer | Sale at price 19.04 - 20.04 per share. | Direct | 1,601,412 | Aug 7, 2023 |
| POLL CLAIRE LOUISE General Counsel | Stock Gift at price 0.00 per share. | Direct | 0 | Aug 7, 2023 |
| POLL CLAIRE LOUISE General Counsel | Sale at price 19.04 - 20.04 per share. | Direct | 966,968 | Aug 7, 2023 |
| HAHN MARK W. CPA Chief Financial Officer | Sale at price 20.64 - 21.45 per share. | Direct | 3,793,381 | Aug 2, 2023 |
| ZACCARDELLI DAVID S Chief Executive Officer | Sale at price 20.64 - 21.45 per share. | Direct | 3,793,381 | Aug 2, 2023 |
| RICKARD KATHLEEN A Officer | Sale at price 20.64 - 21.45 per share. | Direct | 706,614 | Aug 2, 2023 |
| POLL CLAIRE LOUISE General Counsel | Sale at price 20.64 - 21.45 per share. | Direct | 666,241 | Aug 2, 2023 |
| GUPTA RISHI Director | Sale at price 20.00 - 22.26 per share. | Indirect | 9,938,132 | May 15, 2023 |
| ORBIMED ADVISORS, L.L.C. Unknown | Sale at price 20.00 - 22.26 per share. | Indirect | 9,938,132 | May 15, 2023 |
| RICKARD KATHLEEN A Officer | Sale at price 20.72 - 21.19 per share. | Direct | 2,213,480 | May 3, 2023 |
| RICKARD KATHLEEN A Officer | Sale at price 20.72 - 21.19 per share. | Direct | 2,213,480 | May 3, 2023 |
| HAHN MARK W. CPA Chief Financial Officer | Sale at price 20.72 per share. | Direct | 9,438,540 | May 1, 2023 |
| ZACCARDELLI DAVID S Chief Executive Officer | Sale at price 20.72 per share. | Direct | 9,438,706 | May 1, 2023 |
| RICKARD KATHLEEN A Officer | -- | Direct | -- | May 1, 2023 |
| POLL CLAIRE LOUISE General Counsel | Sale at price 20.72 per share. | Direct | 1,665,391 | May 1, 2023 |
| POLL CLAIRE LOUISE General Counsel | Sale at price 20.72 per share. | Direct | 1,665,391 | May 1, 2023 |
| POLL CLAIRE LOUISE General Counsel | -- | Direct | -- | May 1, 2023 |
| RICKARD KATHLEEN A Officer | Sale at price 20.50 - 20.80 per share. | Direct | 2,460,584 | Feb 2, 2023 |
| POLL CLAIRE LOUISE General Counsel | Stock Gift at price 0.00 per share. | Direct | 0 | Feb 1, 2023 |
| POLL CLAIRE LOUISE General Counsel | Sale at price 20.80 per share. | Indirect | 3,161,600 | Feb 1, 2023 |
| RICKARD KATHLEEN A Officer | -- | Direct | -- | Jan 20, 2023 |
| POLL CLAIRE LOUISE General Counsel | -- | Direct | -- | Jan 20, 2023 |
| GUPTA RISHI Director | Sale at price 21.71 - 24.11 per share. | Indirect | 136,000,855 | Dec 23, 2022 |
| POLL CLAIRE LOUISE General Counsel | Sale at price 22.05 per share. | Indirect | 5,292,000 | Dec 22, 2022 |
| HAHN MARK W. CPA Chief Financial Officer | Sale at price 18.59 per share. | Direct | 11,154,000 | Dec 20, 2022 |
| POLL CLAIRE LOUISE General Counsel | Stock Gift at price 0.00 per share. | Direct | 0 | Nov 22, 2022 |
| ZACCARDELLI DAVID S Chief Executive Officer | Sale at price 13.19 per share. | Direct | 434,004 | Nov 1, 2022 |
| ZACCARDELLI DAVID S President | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Sep 26, 2022 |
| RICKARD KATHLEEN A Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Sep 26, 2022 |
| POLL CLAIRE LOUISE General Counsel | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Sep 26, 2022 |
| HAHN MARK W. CPA Chief Financial Officer | Sale at price 10.03 per share. | Direct | 6,018,000 | Aug 9, 2022 |
| ZACCARDELLI DAVID S Chief Executive Officer | Sale at price 10.03 per share. | Direct | 6,018,000 | Aug 9, 2022 |
| RICKARD KATHLEEN A Officer | Sale at price 5.68 per share. | Direct | 163,311 | Aug 2, 2022 |
| HAHN MARK W. CPA Chief Financial Officer | Sale at price 5.63 per share. | Direct | 74,136 | Aug 1, 2022 |
| ZACCARDELLI DAVID S Chief Executive Officer | Sale at price 5.63 per share. | Direct | 185,250 | Aug 1, 2022 |
| POLL CLAIRE LOUISE General Counsel | Stock Gift at price 0.00 per share. | Direct | 0 | Jul 30, 2021 |
| SHAH MAHENDRA G Director | Sale at price 6.72 per share. | Direct | 71,770 | May 4, 2021 |
| SINHA VIKAS CPA Director | Sale at price 6.72 per share. | Direct | 67,308 | May 4, 2021 |
Related Tickers
URGN UroGen Pharma Ltd.
19.20
+9.71%
RCKT Rocket Pharmaceuticals, Inc.
21.86
-4.37%
ANVS Annovis Bio, Inc.
5.85
-2.66%
ARQT Arcutis Biotherapeutics, Inc.
8.63
-7.60%
MDGL Madrigal Pharmaceuticals, Inc.
277.59
+0.21%
CABA Cabaletta Bio, Inc.
10.66
-15.13%
IOVA Iovance Biotherapeutics, Inc.
8.16
-3.20%
GNFT Genfit S.A.
4.0900
-13.89%
VNDA Vanda Pharmaceuticals Inc.
6.24
-4.00%
AXSM Axsome Therapeutics, Inc.
73.63
+1.54%